COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 297: Articles 2961-2970  | Next

COVID-19 vaccination uptake among healthcare workers in Ghana: A comprehensive analysis of knowledge, attitude, perceived vaccine effectiveness, and health belief model constructs
Mbele, W., Dako-Gyeke, P., Frans, A. N.
10.1101/2023.12.05.23299475 — Posted: 2023-12-05
Influenza Mortality as an Indicator of the Efficacy of COVID-Related, Non-pharmaceutical Interventions to Reduce the Spread of Respiratory Infections
Morris, R. D.
10.1101/2023.11.30.23299157 — Posted: 2023-12-05
SARS-CoV-2 Infection is Associated with an Increase in New Diagnoses of Schizophrenia Spectrum and Psychotic Disorder: A Study Using the US National COVID Cohort Collaborative (N3C)
Rahman, A., Russell, M., Zheng, W., Eckrich, D., Ahmed, I., on behalf of the N3C Consortium
10.1101/2023.12.05.23299473 — Posted: 2023-12-05
Supporting young people through the COVID-19 pandemic and beyond: A multi-site qualitative longitudinal study
Whyte, M., Nicol, E., Hawke, L., Wuerth, K., Quinlan-Davidson, M., O'Reilly, A., Duffy, J., Mathias, S., Henderson, J., Barbic, S. P.
10.1101/2023.12.05.23299469 — Posted: 2023-12-05
GotGlycans: Role of N343 Glycosylation on the SARS-CoV-2 S RBD Structure and Co-Receptor Binding Across Variants of Concern
Ives, C. M., Nguyen, L., Fogarty, C. A., Harbison, A. M., Durocher, Y., Klassen, J. S., fadda, e.
10.1101/2023.12.05.570076 — Posted: 2023-12-05
High throughput screening identifies broad-spectrum Coronavirus entry inhibitors
Khan, S., Partuk, E. O., Chiaravalli, J., Kozer, N., Shurrush, K. A., Elbaz-Alon, Y., Scher, N., Giraud, E., Tran-Rajau, J., Agou, F., Barr, H. M., Avinoam, O.
10.1101/2023.12.04.569985 — Posted: 2023-12-05
Identification and Analysis of SARS-CoV-2 Mutation and Subtype using 2x tiled Primer Set with Oxford Nanopore Technologies Sequencing for Enhanced Variant Detection and Surveillance in Seoul, Korea
Han, G., Lee, S., Kwon, Y., Lyu, J., Kim, H., Yoon, K.-J., Kim, M.
10.1101/2023.12.03.569831 — Posted: 2023-12-05
Multi-variate statistical and machine learning reveals the interplay between sex and age in antibody responses to de novo SARS-CoV-2 infection and vaccination
Cuperlovic-Culf, M., Bennett, S., Galipeau, Y., McCluskie, P. S., Arnold, C., Bagheri, S., Cooper, C. L., Langlois, M.-A., Fritz, J., A. Piccirillo, C., Crawley, A. M.
10.1101/2023.12.05.569965 — Posted: 2023-12-05
A Data Science Pipeline Applied to Australia's 2022 COVID-19 Omicron Waves
Trauer, J. M., Hughes, A. E., Shipman, D. S., Meehan, M. T., Henderson, A. S., McBryde, E. S., Ragonnet, R.
10.1101/2023.12.04.23299260 — Posted: 2023-12-05
Expression profile analysis of COVID-19 patients
Shimansky, V. S., Popov, O. S., Klochkova, T. G., Apalko, S. V., Sushentseva, N. N., Anisenkova, A. Y., Mosenko, S. V., Shcherbak, S. G.
10.1101/2023.12.03.23299339 — Posted: 2023-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).